- Home
- UL vs LLY Comparison
UL vs LLY Comparison
Compare UL & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UL | LLY |
|---|---|---|
| Founded | 1930 | 1876 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.0B | 950.7B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | UL | LLY |
|---|---|---|
| Price | $67.45 | $977.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 19 |
| Target Price | N/A | ★ $1,174.53 |
| AVG Volume (30 Days) | ★ 3.4M | 3.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.33% | 0.69% |
| EPS Growth | N/A | ★ 95.99 |
| EPS | N/A | ★ 22.95 |
| Revenue | N/A | ★ $65,179,000,000.00 |
| Revenue This Year | $3.44 | $27.04 |
| Revenue Next Year | $3.72 | $16.26 |
| P/E Ratio | ★ $14.29 | $43.81 |
| Revenue Growth | N/A | ★ 44.70 |
| 52 Week Low | $55.05 | $623.78 |
| 52 Week High | $74.98 | $1,133.95 |
Technical Indicators
Market Signals| Indicator | UL | LLY |
|---|---|---|
| Relative Strength Index (RSI) | 37.19 | 40.32 |
| Support Level | $58.68 | $766.48 |
| Resistance Level | $74.86 | $1,102.49 |
| Average True Range (ATR) | 0.86 | 27.65 |
| MACD | -0.91 | -4.11 |
| Stochastic Oscillator | 2.71 | 15.65 |
Price Performance
Historical ComparisonAbout UL Unilever PLC
Unilever is a diversified beauty, wellbeing, and personal care (44% of 2024 sales by value), homecare (20%), and packaged food (36%) company. Its brands include Dove personal-care products, Knorr soups and sauces, Hellmann's mayonnaise, Axe and Rexona deodorants, and TRESemmé haircare. The firm has been acquisitive in recent years; notable purchases include Paula's Choice, Liquid I.V., Horlicks, and Wild deodorants. The company derives 58% of its sales from emerging markets and 42% from developed markets. The US is its largest market, accounting for around 20% of sales, followed by India, which accounts for 11% of sales.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.